Celgene, 2.25% 15may2019, USD (US151020AN42)

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

International bonds, Senior Unsecured

Status

Matured

Amount

500,000,000 USD

Placement

***

Redemption (put/call option)

*** (-)

ACI on

Country of risk

USA

Current coupon

Price

Yield / Duration

Calculate in two clicks! yield, duration and other parameters

Calculator What is a calculator?

Placement amount

500,000,000 USD
Minimum Settlement Amount

2,000 USD
ISIN

US151020AN42
CFI

DBFUGR
FIGI

BBG006G1NWX4
SEDOL

BMH4PT2
Ticker

CELG 2.25 05/15/19

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Files

Prospectus

Prospectus

Authorization required

It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection

More about Cbonds Estimation

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Issue information

Profile

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Borrower

Go to the issuer page
Celgene
Full borrower / issuer name

Celgene
Sector

Corporate
Industry

Pharmaceutical Preparation and Biotechnology

Volume

Placement amount

500,000,000 USD

Face value

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD
Increment

*** USD
Face value

1,000 USD

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Export to Excel

Early redemption terms

***

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Open subscription
Placement type

Public
Placement

*** - ***
Initial issue price (yield)

(***%)
Geographic breakdown

***
Investor breakdown

***

Participants

Co-arranger

***, ***, ***, ***

Conversion and exchange

Conversion terms

***

Latest issues

Show all

Similar issues

News

11/01/2025	S&P Global Ratings affirms Celgene at "A" (Foreign Currency LT credit rating); outlook stable
11/01/2025	S&P Global Ratings affirms Celgene at "A" (Local Currency LT credit rating); outlook stable
04/01/2024	S&P Global Ratings affirms Celgene at "A" (Foreign Currency LT credit rating); outlook stable
04/01/2024	S&P Global Ratings affirms Celgene at "A" (Local Currency LT credit rating); outlook stable
29/12/2023	S&P Global Ratings downgrades Foreign Currency LT credit rating of Celgene to "A"; outlook stable

All organization news

IFRS/US GAAP reports

2019
	I q eng
	II q eng
	III q eng

2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Identifiers

ISIN

***
Cbonds ID

76051
CUSIP

***
CUSIP 144A

***
CFI

DBFUGR
FIGI

BBG006G1NWX4
WKN

A1ZHX2
SEDOL

BMH4PT2
Ticker

CELG 2.25 05/15/19
Type of security by CBR

***

Bond classification

Senior Unsecured
Registered
Coupon bonds
Amortization
Callable
CDO
Convertible
Dual currency bonds
Variable rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Non-complex financial instruments (MiFID)
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk
Trace-eligible

Show more Hide

Restructuring

***